Health product recall

Riva-Oxazepam: Incorrect label (Riva-Oxazepam 30MG 500 tablets DIN00568414) may be appended to affected lots that contains: Riva-Oxazepam 15MG 500 tablets DIN00568406

Last updated

Summary

Product
Riva-Oxazepam
Issue
Health products - Labelling
What to do

See instructions below. 

Affected products

Brand Product Name Market Authorization Dosage Form Strength Lot
Riva-Oxazepam Riva-Oxazepam 15mg 500comp DIN 00568406 Tablet Oxazepam 15 MG D0522, D0555

Issue

Incorrect label (Riva-Oxazepam 30MG 500 tablets DIN00568414) may be appended to affected lots that contains: Riva-Oxazepam 15MG 500 tablets DIN00568406. 

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Retailers, Wholesalers 

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

LABORATOIRE RIVA INC.
660 Boul. Industriel
Blainville
Quebec
Canada  J7C 3V4

Published by
Health Canada
Audience
General public
Retail
Warehouse
Recall class
Type II
Identification number
RA-64575

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe